… as a potential therapeutic target and promising biomarker in … and its potential application
in the diagnosis, treatment and … as a potential therapeutic target and promising biomarker in …

… miR-30a and cancer in tumorigenesis, we believe that miR-30a may serve as tumor
promising biomarker. Moreover, it would offer a therapeutic target for the treatment of cancer. …

… In this review, we discussed the therapeutic potential of PP2A targeting as well as the
biomarker potential of PP2A dysfunctions in EC, and other gynecologic cancers. Specifically, in …

… Taken together, no matter how the strategy on regulation of ANGPTL3 expression is
different, ANGPTL3 gradually becomes a promising diagnostic and therapeutic target for some …

… participated in tumor biology and affected the clinical treatment, therefore, we suggested that
miR-27a acted as a promising biomarker and potential therapeutic target in various tumors. …

… One of the more promising and exciting applications of MMPs in human cancers is as potential
cancer biomarkers, both diagnostic and prognostic. Below we review their exploitation as …

… can serve as valuable diagnostic and prognostic biomarkers for HCC. Interestingly,
certain subsets of miRNAs have also been identified as potential therapeutic targets for HCC. …

… promising diagnostic biomarkers of patients at early stages, prediction of prognosis, and
monitoring of the patients in response to treatment… , diagnostic biomarker, and therapeutic target …

MicroRNAs (miRNAs) are small single stranded non coding RNA molecules (~22 nucleotides)
which impede protein production by directly interacting with 3’untranslated regions of the …

… Furthermore, failure of ER-α36 degradation is a possible reason for Fulvestrant resistance.
Therefore, ER-α36 is a promising biomarker for tumor behavior and therapeutic response, …